Colgate-Palmolive Company CL Stock Analysis
- NYSE
- Stock
- Market closed · opens Monday 9:30 AM ET
$96.56 down $2.13, 2.16% at close Nov 6
Last close · Previous close $98.69
- Market cap
- $76.98BAt the Nov 6 close
- P/E ratio
- 37.72On last 12 months’ EPS
- Diluted EPS
- $2.56Last 12 months
- Dividend yield
- 2.19%Last 12 months
Price chart
$96.56down $2.13, 2.16%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$98.69Nov 5
- Volume5.46MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume5.09MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $75.96 to $101.18; now $96.56
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
CL beat the S&P 500 in 4 of 7 periods.
| Period | CL and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | CL: up 11.3% S&P 500: down 5.6% | CL beat the S&P 500 by 16.9 percentage points Beat |
| 3M | CL: up 4.4% S&P 500: down 4.1% | CL beat the S&P 500 by 8.5 percentage points Beat |
| YTD | CL: up 25.1% S&P 500: up 8.7% | CL beat the S&P 500 by 16.4 percentage points Beat |
| 1Y | CL: up 28.0% S&P 500: up 10.9% | CL beat the S&P 500 by 17.1 percentage points Beat |
| Long term | ||
| 3Y | CL: up 37.6% S&P 500: up 75.0% +11.2% vs +20.5% a year | CL trailed the S&P 500 by 37.4 percentage points Trailed |
| 5Y | CL: up 39.6% S&P 500: up 67.8% +6.9% vs +10.9% a year | CL trailed the S&P 500 by 28.2 percentage points Trailed |
| 10Y | CL: up 75.7% S&P 500: up 313.1% +5.8% vs +15.2% a year | CL trailed the S&P 500 by 237.4 percentage points Trailed |
$10,000 invested in CL 10 years ago (Nov 4, 2016) would be worth about $17,573 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
CL beat the S&P 500 in 4 of 7 periods.
| Period | CL and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | CL: up 10.7% S&P 500: down 5.6% | CL beat the S&P 500 by 16.3 percentage points Beat |
| 3M | CL: up 3.8% S&P 500: down 4.3% | CL beat the S&P 500 by 8.1 percentage points Beat |
| YTD | CL: up 22.2% S&P 500: up 7.8% | CL beat the S&P 500 by 14.4 percentage points Beat |
| 1Y | CL: up 25.0% S&P 500: up 9.7% | CL beat the S&P 500 by 15.3 percentage points Beat |
| Long term | ||
| 3Y | CL: up 28.4% S&P 500: up 68.8% +8.7% vs +19.1% a year | CL trailed the S&P 500 by 40.4 percentage points Trailed |
| 5Y | CL: up 24.0% S&P 500: up 56.9% +4.4% vs +9.4% a year | CL trailed the S&P 500 by 32.9 percentage points Trailed |
| 10Y | CL: up 38.8% S&P 500: up 252.6% +3.3% vs +13.4% a year | CL trailed the S&P 500 by 213.8 percentage points Trailed |
$10,000 invested in CL 10 years ago (Nov 4, 2016) would be worth about $13,880 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$108.77
Closing high on . Now 11.2% below that record.
Split-adjusted daily closes since Jan 3, 1977.
Stock splits
4
Latest: 2-for-1 on . One share bought before the first split is 16 shares today.
All 4 splits
- 2-for-1
- 2-for-1
- 2-for-1
- 2-for-1
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Sep 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
37.7×The Nov 6 close ÷ diluted EPS over the last 12 months ($2.56)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
CL trades at 37.7× its earnings over the last 12 months, above its 5-year median of 31.7×. In plain terms, buyers are paying about $38 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 3.6×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 267.3×Book value as of Sep 30, 2026
Price relative to accounting equity (book value) per share on the Sep 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 22.2×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 4.92%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $83.16BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Sep 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own CL DCF in Excel. Value Colgate-Palmolive with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $21.28Bup 5.9%
- Net income
- $2.05Bdown 29.4%
- Diluted EPS
- $2.56down 28.3%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | $4.95B | $739.00M | $0.90 |
| Q1 FY25 (Mar 31, 2025) | $4.91B | $690.00M | $0.85 |
| Q2 FY25 (Jun 30, 2025) | $5.11B | $743.00M | $0.91 |
| Q3 FY25 (Sep 30, 2025) | $5.13B | $735.00M | $0.91 |
| Q4 FY25 (Dec 31, 2025) | $5.23B | −$37.00M | −$0.04 |
| Q1 FY26 (Mar 31, 2026) | $5.32B | $646.00M | $0.80 |
| Q2 FY26 (Jun 30, 2026) | $5.36B | $693.00M | $0.86 |
| Q3 FY26 (Sep 30, 2026) | $5.37B | $751.00M | $0.94 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $17.42B | $2.17B | $2.55 |
| FY22 (Dec 31, 2022) | $17.97B | $1.79B | $2.13 |
| FY23 (Dec 31, 2023) | $19.46B | $2.30B | $2.77 |
| FY24 (Dec 31, 2024) | $20.10B | $2.89B | $3.51 |
| FY25 (Dec 31, 2025) | $20.38B | $2.13B | $2.63 |
Margins
- Gross 60.6%
- Operating 14.8%
- Net 9.6%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $3.79BLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$4.37BLast 12 months
- Capital spending$577.00MLast 12 months
- 17.8%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $1.14BLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$1.83BLast 12 months
- Total returned$2.97BLast 12 months
78% of free cash flow
Balance sheet
- $1.53BAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$7.72BAs of Sep 30, 2026
- Net debt$6.19BAs of Sep 30, 2026
- 0.96As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 26.79As of Sep 30, 2026
Total debt divided by shareholders’ equity on the Sep 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 8 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✓Current ratio improved: passed
- ✓Share count didn’t rise: passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- 1,135.8%Last 12 months
Over the last 12 months, Colgate-Palmolive’s net income was 1,135.8% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return. ROE can run this high when equity is small, for example after years of large share buybacks.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 12.4%Last 12 months
Over the last 12 months, Colgate-Palmolive’s net income was 12.4% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $1.55 |
| 2017 | $1.59 |
| 2018 | $1.66 |
| 2019 | $1.71 |
| 2020 | $1.75 |
| 2021 | $1.79 |
| 2022 | $1.86 |
| 2023 | $1.91 |
| 2024 | $1.98 |
| 2025 | $2.06 |
| 2026 (to date) | $2.11 |
Dividend details
- $2.11Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- 2.19%; 5-yr low 1.67%, 5-yr high 3.26%Last 12 months
Dividends paid over the last 12 months as a share of the Nov 6 close. The bar shows where that yield sits in its range over the past five years; the median was 2.34%.
- $0.53Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- up 3.3% a yearFull years 2020–2025
The compound annual growth rate of the full-year dividend per share from 2020 to 2025.
- 37 yearsThrough 2025
How many calendar years in a row the full-year amount has risen, through 2025.
- 82.4%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About Colgate-Palmolive Company
Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Headquarters
- New York, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE
- Asset type
- Common stock
- Price history since
CL news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
CL stock FAQ
What is CL stock’s price today?
Colgate-Palmolive (CL) traded at $96.56 at the close on , down $2.13 (2.16%) from the previous close of $98.69. Over the past 52 weeks it has traded between $75.96 and $101.18.
If you invested $1,000 in CL 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in CL on would be worth about $1,757 at the close on , a total return of +75.7%. The same $1,000 would be worth $1,396 if invested five years ago, $1,280 if invested one year ago, $4,816 if invested 20 years ago, and $15,564 if invested 30 years ago. Past performance doesn’t predict future returns.
What is Colgate-Palmolive’s market cap?
Colgate-Palmolive’s market capitalization is about $77.0 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $96.56 (how market cap works). Colgate-Palmolive reported 797.17M shares outstanding at the end of its latest quarter ().
What is CL’s P/E ratio?
CL trades at 37.7 times its diluted earnings over the four quarters to ($2.56 per share), at the close. Over the past five years its P/E has ranged from 20.9 to 43.2, with a median of 31.7. (How the P/E ratio works.)
How much revenue does Colgate-Palmolive make?
Colgate-Palmolive reported $21.3 billion of revenue over the four quarters to , up 5.9% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $5.4 billion, up 4.6% from a year earlier.
Is Colgate-Palmolive profitable?
Yes. Colgate-Palmolive earned $2.1 billion of net income over the four quarters to , a net margin of 9.6%, and its operating margin was 14.8% (what margins tell you).
What are CL’s earnings per share?
CL’s diluted earnings per share were $2.56 over the four quarters to , compared with $3.57 in the twelve months before. The latest quarter (Q3 FY26) brought $0.94 per share, against $0.91 a year earlier (how EPS works).
Does CL pay a dividend?
Yes. Colgate-Palmolive pays a quarterly dividend. The most recent was $0.53 per share, with an ex-dividend date of . Over the last twelve months it paid $2.11 per share, a 2.19% yield at the close, and the full-year dividend has risen 37 years in a row (how dividend yield works).
Based on the last 12 months’ payments ($2.11 per share), and if the next 12 months match the last 12, 100 shares would receive about $211 over 12 months, and $1,000 over 12 months would take about 474 shares, roughly $45,769 at the close. Dividends can change.
What is CL’s 52-week high and low?
Over the past 52 weeks CL has traded as low as $75.96 and as high as $101.18. At $96.56 at the close on , it is 4.6% below that high and 27.1% above the low.
What is CL’s all-time high?
CL’s highest closing price was $108.77 on , adjusted for stock splits. At $96.56 at the close on , it is 11.2% below that record.
Has CL stock ever split?
Yes, four times: 2-for-1 on ; 2-for-1 on ; 2-for-1 on ; 2-for-1 on . One share bought before the first split would be 16 shares today.
How has CL stock performed?
Including dividends and measured to the close on , CL has returned +25.1% so far this year and +28.0% over the past year, and +39.6% over five years (+6.9% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Colgate-Palmolive in?
Colgate-Palmolive is in the Consumer Defensive sector and the Household & Personal Products industry, and is headquartered in New York, USA.
What exchange does CL trade on?
Colgate-Palmolive trades on the NYSE under the ticker symbol CL. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.